Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-21

Clinical Trial Update: Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of a fixed-dose combination of olmesartan and indapamide versus the isolated drugs for hypertension.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indapamide (Indapamide)
  • Olmesartan (olmesartan)
  • Olmesartan + Indapamide fixed-dose combination

Snippet

Sponsor: Brainfarma Industria Química e Farmacêutica S/A | Conditions: Hypertension, Hypertension,Essential | Phase 3 | Status: UNKNOWN